Compare AURA & EVOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | EVOX |
|---|---|---|
| Founded | 2007 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.5M | 318.4M |
| IPO Year | 2021 | 2025 |
| Metric | AURA | EVOX |
|---|---|---|
| Price | $5.70 | $10.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.20 | N/A |
| AVG Volume (30 Days) | ★ 188.2K | 102.0K |
| Earning Date | 03-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $9.86 |
| 52 Week High | $8.16 | $10.09 |
| Indicator | AURA | EVOX |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 54.80 |
| Support Level | $5.26 | $9.98 |
| Resistance Level | $5.82 | $10.09 |
| Average True Range (ATR) | 0.32 | 0.03 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 34.83 | 40.00 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Evolution Global Acquisition Corp is a blank check company.